1. Mavridis D, Moustaki I, Wall M, Salanti G. Detecting outlying studies in meta‐regression models using a forward search algorithm. Res Synth Meth 2016 [Epub ahead of print]

  2. Efthimiou O, Debray T, Valkenhoef G, Trelle S, Panayidou K, Moons KGM, Reitsma JB, Shang A, Salanti G. GetReal in network meta‐analysis: a review of the methodology. Res Synth Meth 2016 [Epub ahead of print

  3. Samara MT, Dold M, Gianatsi M, Nikolakopoulou A, Helfer B, Salanti G, Leucht S. Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia. A Network Meta-analysis. JAMA Psychiatry 2016 [Epub ahead of print]

  4. Terkawi AS, Mavridis D, Flood P, Wetterslev J, Terkawi RS, Bin Abdulhak AA, Nunemaker MS, Tiouririne M. Does ondansetron modify sympathectomy due to subarachnoid anesthesia?: meta-analysis, meta-regression, and trial sequential analysis. Anesthesiology 2016 [Epub ahead of print]

  5. Efthimiou O, Debray T, Valkenhoef G, Trelle S, Panayidou K, Moons KGM, Reitsma JB, Shang A, Salanti G. GetReal in network meta‐analysis: a review of the methodology. Res Synth Meth 2016 [Epub ahead of print]

  6. Nikolakopoulou A. Mavridis D, Salanti G. Planning future studies based on the precision of network meta-analysis results. Stat Med 2015 [Epub ahead of print]

  7. Chaimani A, Salanti G. Visualizing assumptions and results in network meta-analysis: the network graphs package. Stata Journal 2015; 15(4): 905-950

  8. Debray TPA, Moons KGM, van Valkenhoef G, Efthimiou O, Hummel N, Groenwold RHH, Reitsma JB on behalf of the GetReal methods review group. Get real in individual participant data (IPD) meta-analysis: a review of the methodology. Res Syn Meth 2015; 6: 293–309

  9. Dimitrakopoulou V, Efthimiou O, Leucht S, Salanti G. Accounting for uncertainty due to ‘last observation carried forward’ outcome imputation in a meta-analysis model. Stat Med 2015; 34: 742–752

  10. Vasiliadis HS, Nikolakopoulou A, Shrier I, Lunn MP, Brassington R, Scholten RJP, et al. Endoscopic and open release similarly safe for the treatment of carpal tunnel syndrome. A systematic review and meta-analysis. Plos One 2015; 10(12): e0143683

  11. Jackson D, Law M, Barrett KJ, Turner R, Higgins J, Salanti G, White I. Extending DerSimonian and Laird's methodology to perform network meta‐analyses with random inconsistency effects. Stat Med 2015 [Epub ahead of print]

  12. Veroniki AA, Jackson D, Viechtbauer W, Bender R, Bowden J, Knapp G, Kuss O, Higgins J, Langan D, Salanti G. Methods to estimate the between‐study variance and its uncertainty in meta‐analysis. Res Synth Meth 2015 [Epub ahead of print]

  13. Pandis N, Fleming PS, Worthington H, Dwan K, Salanti G. Discrepancies in Outcome Reporting Exist Between Protocols and Published Oral Health Cochrane Systematic Reviews. Plos One 2015; 10(9): e0137667

  14. Siontis GCM, Stefanini GG, Mavridis D, Siontis KC, Alfonso F, Perez-Vizcayno MJ, Byrne RA, Kastrati A, Meier B, Salanti G, Juni P, Windecker S. Percutaneous coronary interventional strategies for treatment of in-stent restenosis: a network meta-analysis. The Lancet 2015; 386(9994): 655-664

  15. Pandis N, Fleming PS, Worthington H, Salanti G. The quality of the evidence according to GRADE is predominantly low or very low in oral health systematic reviews. PloS One 2015; 10(7),e0131644

  16. Mavridis D, Efthimiou O, Leucht S, Salanti G. Publication bias and small-study effects magnified effectiveness of antipsychotics but their relative ranking remained invariant. JCE 2016; 69: 161-169

  17. Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklists and explanations. Ann Int Med 2015; 162(11):777-784

  18. Palmer SC, Mavridis D, Navarese E, Craig JC, Tonelli M, Salanti G,Wiebe N, Ruospo M, Wheeler DC, Strippoli GFM. Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: A network meta-analysis. The Lancet 2015; 385(9982):2047-56

  19. Mavridis D, Giannatsi M, Cipriani A, Salanti G. A primer on network meta-analysis with emphasis on mental health.  Evid Based Mental Health 2015; 18(2):40-46.

  20. Helfer B, Prosser A, Samara MT, Geddes JR, Cipriani A, Davis JM, Mavridis D, Salanti G, Leucht S. Recent meta-analyses neglect previous systematic reviews and meta-analyses about the same topic: a systematic examination. BMC Medicine 2015; 13(1):82

  21. Spinelli LM, Pandis N, Salanti G. Reporting and handling missing outcome data in mental health: a systematic review of Cochrane systematic reviews and meta-analyses. Research Synthesis Methods 2015; 6(2): 175-187

  22. Chaimani A. Accounting for baseline differences in meta-analysis. Evid Based Mental Health 2015;18:23-26.

  23. Mavridis D, Welton NJ, Sutton A, Salanti G. A selection model for accounting for publication bias in a full network meta‐analysis. Stat Med. 2014; 33: 5399-5412.

  24. Veroniki AA, Mavridis D, Higgins JP, Salanti G. Characteristics of a loop of evidence that affect detection and estimation of inconsistency: a simulation study.BMC Med Res. Methodol. 2014 Sep 19;14(1):106.

  25. Chaimani A, Mavridis D, Salanti G. A hands-on practical tutorial on performing meta-analysis with Stata. Evid Based Mental Health 2014;17:111-116.

  26. Nikolakopoulou A, Mavridis D, Salanti G. Using conditional power of network meta-analysis (NMA) to inform the design of future clinical trials. Biom J. 2014 Sep 16

  27. Efthimiou O, Mavridis D, Cipriani A, Leucht S, Bagos P, Salanti G. An approach for modelling multiple correlated outcomes in a network of interventions using odds ratios. Stat Med. 2014 Jun 15;33(13):2275-87.

  28. Efthimiou O, Mavridis D, Riley RD, Cipriani A, Salanti G.Joint synthesis of multiple correlated outcomes in networks of interventions.Biostatistics. 2014 Jul 2. pii: kxu030.

  29. Mavridis D, Chaimani A, Efthimiou O, Leucht S, Salanti G. Addressing missing outcome data in meta-analysisEvid Based Ment Health. 2014 Aug;17(3):85-9.

  30. Mavridis D, Chaimani A, Efthimiou O, Salanti G. Missing outcome data in meta-analysis.Evid Based Ment Health. 2014 Jul 9. pii: ebmental-2014-101899. 

  31. Nikolakopoulou A, Mavridis D, Salanti G. How to interpret meta-analysis models: fixed effect and random effects meta-analyses. Evid Based Ment Health. 2014 May;17(2):64.

  32. Nikolakopoulou A, Mavridis D, Salanti G.Demystifying fixed and random effects meta-analysis.Evid Based Ment Health. 2014 May;17(2):53-7.

  33. Salanti G, Del Giovane C, Chaimani A, Caldwell DM, Higgins JPT. Evaluating the quality of evidence from a network meta-analysis. PloS One 2014. Jul 3;9(7):e99682

  34. Pandis N, Fleming PS, Spineli LM, Salanti G. Initial orthodontic alignment effectiveness with self-ligating and conventional appliances: A network meta-analysis in practice. Am J Orthod Dentofacial Orthop. 2014 Apr;145(4):152-163.

  35. Hutton B, Salanti G, Chaimani A, Caldwell DM, Schmid C, Thorlund K, Mills E, Catalá-López F, Turner L, Altman DG, Moher D.The quality of reporting methods and results in network meta-analyses: an overview of reviews and suggestions for improvement. PLoS One. 2014 Mar 26;9(3):e92508.

  36. Jansen JP, Trikalinos T, Cappelleri JC, Daw J, Andes S, Eldessouki R, Salanti G. Indirect Treatment Comparison/Network Meta-Analysis Study Questionnaire to Assess Relevance and Credibility to Inform Health Care Decision Making: An ISPOR-AMCP-NPC Good Practice Task Force Report. Value Health. 2014 Mar;17(2):157-73. 

  37. Efthimiou O, Mavridis D, Cipriani A, Leucht S, Bagos P, Salanti G. An approach for modelling multiple correlated outcomes in a network of interventions using odds ratios. Stat Med 2014 (early view)

  38. Vasiliadis HS, Georgoulas P, Shrier I, Salanti G, Scholten RJ. Endoscopic release for carpal tunnel syndrome.Cochrane Database Syst Rev. 2014 Jan 31;1:CD008265. 

  39. Mavridis D, Salanti G.How to assess publication bias: funnel plot, trim-and-fill method and selection models. Evid Based Ment Health. 2014 Feb;17(1):30.

  40. Mavridis D, Salanti G. Exploring and accounting for publication bias in mental health: a brief overview of methods.  Evid Based Ment Health. 2014 Feb;17(1):11-5.

  41. Nikolakopoulou A, Chaimani A, Veroniki AA, Vasiliadis HS, Schmid CH,Salanti G. Characteristics of networks of interventions: a description of a database of 186 published networks.PLoS One. 2014 Jan 22;9(1):e86754.

  42. McKenzie JE,Salanti G, Lewis SC, Altman DG.  Meta-analysis and The Cochrane Collaboration: 20 years of the Cochrane Statistical Methods Group. Syst Rev 2013 Nov 26;2(1):80. 

  43. Chaimani A, Higgins JP, Mavridis D, Spyridonos P, Salanti G. Graphical Tools for Network Meta-Analysis in STATA. PLoS One. 2013 Oct 3;8(10):e76654.

  44. Cipriani A., Higgins JPT, Geddes JR, Salanti G. Conceptual and technical challenges in network meta-analysis. Annals of Internal Medicine 2013 Jul 16;159(2):130-7.

  45. Chaimani A,  Vasiliadis HS, Pandis N, Christopher  HS, Welton NJ, Salanti G. Effects of study precision and risk of bias in networks of interventions: a network meta-epidemiological study. International Journal of Epidemiology. 2013 Aug;42(4):1120-31

  46. Leucht S, Cipriani A, Spineli L,  Mavridis D, Örey D, Richter R, Barbui C, Leucht C, Engel RR, Geddes JR, Salanti G, Davis J. Multiple-treatments meta-analysis on the efficacy, acceptability and tolerability of 15 antipsychotics drugs in schizophrenia. The Lancet 2013. Sep 14;382(9896):951-62

  47. Filippini G., Vacchi L, Del Giovane C, D'Amico R, Di Pietrantonj C, Beecher D, Salanti G. Comparative efficacy and acceptability of immunomodulators and immunosuppressants for multiple sclerosis: overview of Cochrane systematic reviews and multiple-treatments meta-analysis.  Cochrane Database Syst Rev. 2013 Jun 6;6:CD008933. 

  48. Veroniki AA, Vasiliadis HS, Higgins JP, Salanti G.Evaluation of inconsistency in networks of interventions. Int J Epidemiol. 2013 Feb;42(1):332-45.

  49. Spineli LM ,Higgins JPT, Cipriani A, Leucht S,Salanti G Evaluating the impact of imputations for missing participant outcome data in a network meta-analysis Clinical Trials 2013 Jan 15.

  50. Veroniki AA, Pavlides M, Patsopoulos NA, Salanti G. Reconstructing 2x2 contingency tables from odds ratios using the Di Pietrantonj method: difficulties, constraints and impact in meta-analysis results. Accepted by Research Synthesis Methods.

  51. Moja L, Piatti A, Pecoraro V, Ricci C, Virgili G, Salanti G. Germagnoli L, Liberati A, Banfi G.Timing Matters in Hip Fracture Surgery: Patients Operated within 48 Hours Have Better Outcomes. A Meta-Analysis and Meta-Regression of over 190,000 Patients. PLoS One. 2012;7(10):e46175.

  52. Salanti G. Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool. Research Synthesis Methods. 2012 3 (2): 80.

  53. Chaimani A, Salanti G. Using network meta-analysis to evaluate the existence of small-study effects in a network of interventions. Research Synthesis Methods 2012 3 (2):161. The WinBUGS models and data can be found here.

  54. Mavridis D, Sutton A, Cipriani A, Salanti G. A fully Bayesian application of the Copas selection model for publication bias extended to network meta-analysis.Stat Med (early view). The WinBUGS models and data can be found here.

  55. Del Giovane C, Filippini G, Vacchi L, Mavridis D, Salanti G. Network meta-analysis models to account for variability in treatment definitions: application to dose effects.Stat Med (early view). The WinBUGS models can be found here.

  56. Mavridis D, Salanti G. A practical introduction to multivariate meta-analysis.Stat Methods Med Res. 2012 Jan 23. [Epub ahead of print]. Supporting sofware routines and codes can be found here.

  57. Jansen JP, Schmid CH, Salanti G. Directed acyclic graphs can help understand bias in indirect and mixed treatment comparisons.J Clin Epidemiol. 2012 Jul;65(7):798-807.

  58. Cipriani A, Barbui C, Rizzo C, Salanti G.What is a multiple treatments meta-analysis?Epidemiol Psychiatr Sci. 2012 Jun;21(2):151-3.

  59. Leucht S, Tardy M, Komossa K, Heres S, Kissling W, Salanti G, Davis JM. Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis.Lancet. 2012 Jun 2;379(9831):2063-71.

  60. Cipriani A, Barbui C, Salanti G et al. Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis. Lancet. 2011 Oct 8;378(9799):1306-15.

  61. Manzoli L, De Vito C, Salanti G et al. Meta-Analysis of the Immunogenicity and Tolerability of Pandemic Influenza A 2009 (H1N1) Vaccines. PLoS One. 2011;6(9):e24384.

  62. Rizos EC, Salanti G, Kontoyiannis DP, Ioannidis JP. Homophily and co-occurrence patterns shape randomized trials agendas: illustration in antifungal agents.J Clin Epidemiol. 2011 Aug;64(8):830-42.

  63. Salanti G, Ades AE, Ioannidis JP. Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial.J Clin Epidemiol. 2011 Feb;64(2):163-71.

  64. Salanti G, Dias S, Welton NJ et al. Evaluating novel agent effects in multiple-treatments meta-regression. Stat Med. 2010 Oct 15;29(23):2369-83.

  65. Dias S, Welton N, Marinho VCC, Salanti G, Ades AE. Estimation and adjustment of Bias in randomised evidence using Mixed Treatment Comparison Meta-analysis.Journal of the Royal Stat. Soc. (A) 2010 (173): 613-29

  66. Barbui C, Cipriani A, Furukawa T, Salanti G et al. Making the best use of available evidence: the case of new generation antidepressants: a response to: are all antidepressants equal? Evid Based Ment Health. 2009 Nov;12(4):101-4.

  67. Manzoli L, Salanti G, De Vito C, Boccia A, Ioannidis JP, Villari P. Immunogenicity and adverse events of avian influenza A H5N1 vaccine in healthy adults: multiple-treatments meta-analysis Lance Infect Dis. 2009 Aug;9(8):482-92. 

  68. Golfinopoulos V, Pentheroudakis G, Salanti G et al. Comparative survival with diverse chemotherapy regimens for cancer of unknown primary site: multiple-treatments meta-analysis. Cancer Treat Rev. 2009 Nov;35(7):570-3.

  69. Cipriani A, Furukawa TA, Salanti G et al. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet. 2009 Feb 28;373(9665):746-58.

  70. Salanti G, Marinho V, Higgins JP. A case study of multiple-treatments meta-analysis demonstrates that covariates should be considered.J Clin Epidemiol. 2008 Aug;62(8):857-64.

  71. Mauri D, Polyzos N, Salanti G, Pavlidis N, Ioannidis J. Multiple treatments meta-analysis of chemotherapy and targeted therapy regimens in advanced breast cancer. J Natl Cancer Inst. 2008 Dec 17;100(24):1780-91.

  72. Salanti G, Kavvoura FK, Ioannidis JP. Exploring the geometry of treatment networks. Ann Intern Med. 2008 Apr 1;148(7):544-53.

  73. Salanti G, Higgins JP, Ades A, Ioannidis JP. Evaluation of networks of randomized trials. Stat Methods Med Res. 2007 Jun;17(3):279-301. 

  74. Golfinopoulos V, Salanti G, Pavlidis N, Ioannidis JP. Survival and disease-progression benefits with treatment regimens for advanced colorectal cancer: a meta-analysis. Lancet Oncol. 2007 Oct;8(10):898-911.

  75. Kyrgiou M, Salanti G, Pavlidis N, Paraskevaidis E, Ioannidis JP. Survival benefits with diverse chemotherapy regimens for ovarian cancer: meta-analysis of multiple treatments.J Natl Cancer Inst. 2006 Nov 15;98(22):1655-63.

Additional information